Advertisement

Topics

Follow-on offering nets $140.5mm for Array BioPharma

15:41 EDT 29 Sep 2016 | Elsevier Business Intelligence

Array BioPharma Inc. (mainly developing cancer therapies; also has projects in the pipeline for infectious, cardiovascular, and respiratory conditions) netted $140.5mm through the public sale of 23.9mm common shares (including the overallotment) at $6.25.

Original Article: Follow-on offering nets $140.5mm for Array BioPharma

NEXT ARTICLE

More From BioPortfolio on "Follow-on offering nets $140.5mm for Array BioPharma"

Quick Search
Advertisement
 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...